Swapan K Ray Selected Research

retinamide

1/2020	Synergism of 4HPR and SAHA increases anti-tumor actions in glioblastoma cells.
5/2012	Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells.
11/2011	Synergistic efficacy of a novel combination therapy controls growth of Bcl-x(L) bountiful neuroblastoma cells by increasing differentiation and apoptosis.
9/2011	Combination of N-(4-hydroxyphenyl) retinamide and apigenin suppressed starvation-induced autophagy and promoted apoptosis in malignant neuroblastoma cells.
6/2011	Induction of Mitochondrial Pathways and Endoplasmic Reticulum Stress for Increasing Apoptosis in Ectopic and Orthotopic Neuroblastoma Xenografts.
4/2011	N-(4-Hydroxyphenyl) Retinamide Potentiated Anti-tumor Efficacy of Genistein in Human Ewing's Sarcoma Xenografts.
11/2010	Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo.
11/2009	N-Myc down regulation induced differentiation, early cell cycle exit, and apoptosis in human malignant neuroblastoma cells having wild type or mutant p53.
5/2009	N-(4-Hydroxyphenyl) retinamide potentiated paclitaxel for cell cycle arrest and apoptosis in glioblastoma C6 and RG2 cells.
8/2008	N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Swapan K Ray Research Topics

Disease

49	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 07/2002
46	Neoplasms (Cancer) 12/2021 - 07/2002
26	Spinal Cord Injuries (Spinal Cord Injury) 02/2022 - 05/2003
23	Neuroblastoma 01/2016 - 12/2006
15	Inflammation (Inflammations) 10/2020 - 05/2008
9	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2017 - 05/2004
9	Wounds and Injuries (Trauma) 01/2017 - 05/2003
8	Multiple Sclerosis 10/2019 - 06/2008
8	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2019 - 10/2008
8	Demyelinating Diseases (Demyelinating Disease) 10/2019 - 06/2008
7	Gliosis 01/2019 - 06/2010
5	Alzheimer Disease (Alzheimer's Disease) 11/2019 - 06/2008
5	Brain Neoplasms (Brain Tumor) 08/2013 - 07/2002
4	Parkinson Disease (Parkinson's Disease) 12/2017 - 06/2008
4	Optic Neuritis (Retrobulbar Neuritis) 10/2016 - 08/2005
4	Parkinsonian Disorders (Parkinsonism) 10/2008 - 08/2006
3	Pathologic Processes 11/2019 - 01/2013
3	Starvation 07/2019 - 09/2011
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2017 - 01/2016
3	Nervous System Diseases (Neurological Disorders) 01/2016 - 06/2008
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2013 - 08/2005
3	Edema (Dropsy) 05/2008 - 12/2004
2	Neuroinflammatory Diseases 11/2019 - 10/2014
2	Amyloid Plaque 11/2019 - 06/2008
2	Brain Injuries (Brain Injury) 01/2017 - 01/2016
2	Vision Disorders (Hemeralopia) 10/2016 - 07/2011
2	Stroke (Strokes) 01/2016 - 01/2006
2	Necrosis 12/2015 - 12/2007

Drug/Important Bio-Agent (IBA)

31	CalpainIBA 11/2016 - 06/2002
15	Estrogens (Estrogen)FDA Link 02/2017 - 11/2004
12	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2002
11	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2020 - 12/2007
11	Peptide Hydrolases (Proteases)FDA Link 03/2016 - 06/2003
10	retinamideIBA 01/2020 - 08/2008
10	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2019 - 05/2007
10	RetinoidsIBA 11/2019 - 03/2008
10	Caspase 3 (Caspase-3)IBA 03/2016 - 07/2002
10	GenisteinIBA 01/2013 - 12/2006
10	Paclitaxel (Taxol)FDA LinkGeneric 12/2012 - 11/2007
10	FenretinideIBA 05/2012 - 03/2008
10	CaspasesIBA 11/2010 - 05/2003
9	calpain inhibitorsIBA 10/2016 - 05/2003
9	Small Interfering RNA (siRNA)IBA 10/2013 - 01/2009
9	Interferon-gamma (Interferon, gamma)IBA 07/2010 - 05/2007
8	MicroRNAs (MicroRNA)IBA 02/2022 - 05/2012
8	Neuroprotective AgentsIBA 01/2017 - 11/2004
8	ApigeninIBA 10/2013 - 12/2006
8	Cysteine Proteases (Cysteine Protease)IBA 04/2011 - 05/2003
7	CytokinesIBA 11/2019 - 08/2011
6	SurvivinIBA 04/2016 - 12/2007
6	FlavonoidsIBA 03/2016 - 12/2006
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 12/2007
6	calpeptinIBA 07/2011 - 08/2005
5	MelatoninIBA 01/2013 - 05/2008
5	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2008 - 06/2002
4	SphingosineIBA 10/2019 - 01/2017
4	CeramidesIBA 10/2019 - 01/2017
4	Caspase 8 (Caspase-8)IBA 03/2016 - 12/2006
4	Pharmaceutical PreparationsIBA 08/2015 - 03/2008
3	EnzymesIBA 01/2018 - 01/2006
3	Biological ProductsIBA 12/2017 - 08/2008
3	SphingolipidsIBA 12/2017 - 01/2017
3	AntigensIBA 10/2016 - 01/2011
3	Transcription Factors (Transcription Factor)IBA 06/2013 - 04/2011
3	gallocatechol (epigallocatechin)IBA 02/2013 - 12/2006
3	TeaIBA 02/2013 - 08/2011
3	Myelin Basic ProteinIBA 01/2013 - 10/2003
3	CurcuminIBA 12/2012 - 10/2006
3	Phosphotransferases (Kinase)IBA 05/2011 - 09/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2011 - 09/2007
3	SteroidsIBA 06/2010 - 12/2004
3	p38 Mitogen-Activated Protein KinasesIBA 01/2010 - 09/2007
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2008 - 12/2007
3	RotenoneIBA 10/2008 - 08/2006
3	Temozolomide (Temodar)FDA LinkGeneric 05/2008 - 12/2004
3	Dexamethasone (Maxidex)FDA LinkGeneric 05/2008 - 12/2004
3	Caspase 9IBA 03/2008 - 07/2002
2	ChemokinesIBA 11/2019 - 01/2016
2	Retinoid X Receptors (Retinoid X Receptor)IBA 11/2019 - 01/2016
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 11/2019 - 01/2016
2	Amyloid beta-PeptidesIBA 11/2019 - 06/2008
2	Serine C-PalmitoyltransferaseIBA 10/2019 - 01/2017
2	Acridine OrangeIBA 07/2019 - 09/2011
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2018 - 08/2013
2	Estrogen ReceptorsIBA 01/2017 - 10/2014
2	Neurofilament ProteinsIBA 10/2016 - 01/2013
2	LuteolinIBA 03/2016 - 12/2015
2	Silybin (Lagosa)IBA 03/2016 - 12/2015
2	Sirolimus (Rapamycin)FDA Link 03/2016 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2011
2	diallyl trisulfideIBA 08/2013 - 09/2007
2	Matrix Metalloproteinases (MMPs)IBA 06/2013 - 11/2009
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2013 - 03/2007

Therapy/Procedure

36	Therapeutics 02/2022 - 04/2005
8	Aftercare (After-Treatment) 01/2019 - 12/2007
8	Drug Therapy (Chemotherapy) 03/2016 - 07/2002
2	Complementary Therapies (Alternative Medicine) 01/2018 - 12/2015
2	Lasers (Laser) 01/2016 - 08/2012
2	Intraperitoneal Injections 08/2013 - 07/2011
2	Photochemotherapy (Photodynamic Therapy) 01/2013 - 03/2007